Ignite Creation Date:
2024-05-05 @ 5:27 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00452413
Status:
COMPLETED
Last Update Posted:
2021-05-13
First Post:
2007-03-23
Brief Title:
A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-Small Cell Lung Cancer |
| Malignant Solid Tumor |
Keywords: